Stuart L Silverman
Overview
Explore the profile of Stuart L Silverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reginster J, Silverman S, Alokail M, Al-Daghri N, Hiligsmann M
JBMR Plus
. 2024 Dec;
9(1):ziae138.
PMID: 39664931
Radiofrequency echographic multi-spectrometry (REMS) is an innovative, non-ionizing diagnostic technique that has shown high accuracy and precision, making it a promising alternative to DXA for osteoporosis diagnosis in clinical settings....
2.
Sharma M, Beaudart C, Clark P, Fujiwara S, Adachi J, Papaioannou A, et al.
Osteoporos Int
. 2024 Oct;
36(1):71-80.
PMID: 39432087
Purpose: This part of the Improving Risk Communication in Osteoporosis (RICO) study aims to understand patients' willingness to initiate osteoporosis treatment given a hypothetical fracture probability-derived from the FRAX® Risk...
3.
Reginster J, Czerwinski E, Wilk K, Borowy P, Strzelecka A, Budlewski T, et al.
Osteoporos Int
. 2024 Jul;
35(11):1919-1930.
PMID: 39042292
Purpose: To demonstrate equivalence of candidate biosimilar CT-P41 and US reference denosumab (US-denosumab) in postmenopausal women with osteoporosis. Methods: This 78-week (18-month), double-blind, randomized, active-controlled Phase 3 study (NCT04757376) comprised...
4.
Kanis J, Harvey N, Lorentzon M, Liu E, Schini M, Abrahamsen B, et al.
Osteoporos Int
. 2024 Jul;
35(9):1487-1496.
PMID: 38960982
Task Force on 'Clinical Algorithms for Fracture Risk' commissioned by the American Society for Bone and Mineral Research (ASBMR) Professional Practice Committee has recommended that FRAX® models in the US...
5.
Hiligsmann M, Silverman S, Singer A, Pearman L, Wang Y, Caminis J, et al.
Aging Clin Exp Res
. 2024 Jan;
36(1):14.
PMID: 38289413
Background: Osteoporotic-related fractures represent an increasing burden to patients, health care systems and society. Aims: This study estimated cost-effectiveness of sequential treatment with abaloparatide (ABL) followed by alendronate (ALN) compared...
6.
Moon R, Reginster J, Al-Daghri N, Thiyagarajan J, Beaudart C, Bruyere O, et al.
Osteoporos Int
. 2023 Jun;
34(8):1283-1299.
PMID: 37351614
Purpose: Vast amounts of data are routinely generated at every healthcare contact and activity, and there is increasing recognition that these real-world data can be analysed to generate scientific evidence....
7.
Teigland C, Pulungan Z, Schinkel J, Agatep B, Yeh E, McDermott M, et al.
J Am Med Dir Assoc
. 2023 Jun;
24(10):1533-1540.
PMID: 37271183
Objective: Describe patient characteristics, health care resource utilization, costs, and humanistic burden of women with Medicare insurance with incident fragility fracture who were admitted to post-acute-care (PAC). Design: Retrospective cohort...
8.
Qu H, Silverman S, Shewchuk R, Curtis J, Austin S, Greenspan S, et al.
Risk Manag Healthc Policy
. 2022 Jul;
15:1293-1302.
PMID: 35818434
Objective: Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an...
9.
Nowell W, Gavigan K, Silverman S
Curr Rheumatol Rep
. 2022 Apr;
24(5):119-131.
PMID: 35486218
Purpose Of Review: Changing attitudes about marijuana have led to an increase in use of medicinal marijuana, especially for painful chronic conditions. Patients ask rheumatologists for guidance on this topic....
10.
Bhattoa H, Cavalier E, Eastell R, Heijboer A, Jorgensen N, Makris K, et al.
Clin Chim Acta
. 2020 Dec;
515:16-20.
PMID: 33382995
Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis...